Fractional Roles Gain Traction in Biopharma Amid Industry Challenges

In the face of ongoing industry uncertainties, biopharma professionals are increasingly turning to fractional roles as a viable career option. A recent BioSpace poll reveals that 22% of respondents have experience with fractional positions, while 54% are considering this alternative work arrangement. This shift comes as the pharmaceutical sector grapples with layoffs, regulatory challenges, and funding constraints.

Rising Demand for Fractional Workers

The demand for fractional workers, particularly senior-level professionals, has seen a notable uptick over the past year. Jim Rudman, CEO and founder of Ashton Tweed, notes that companies, especially those in the clinical stage, are hesitant to make permanent hires without a clear financial runway. This caution has led to increased interest in fractional roles across various departments.

Julie Heneghan, president and founder of The Steely Group, observes that companies of all sizes are seeking fractional workers for key positions such as medical directors, chief medical officers, and senior regulatory professionals. The flexibility offered by these arrangements allows businesses to access needed expertise without committing to full-time hires.

Adapting to Industry Challenges

For many biopharma professionals, fractional work represents a strategic adaptation to current market conditions. Alicia Volmar, founder of LIT Discoveries, exemplifies this trend. Following her layoff from Prime Medicine, Volmar launched her own consultancy while exploring fractional scientist roles in the Boston area.

"Having a full-time position is ideal, but I'm just trying to adapt to how things are and may be for a while," Volmar explains. Her approach highlights the proactive measures professionals are taking to navigate the challenging job market.

The Appeal of Variety and Flexibility

Matt Feldman, a scientific communications consultant and CEO of InTheDistance Media, transitioned to fractional work following workforce reductions at Novavax. Feldman finds the variety inherent in fractional roles particularly appealing. "I'm not someone who wants to keep doing that same thing, turning the wheel of the widget machine every day," he states. "So, the variety—the challenge and change—that's a feature, not a bug."

While fractional work offers exciting opportunities, professionals like Feldman also acknowledge potential challenges, such as managing retirement savings without full-time employment benefits. Nevertheless, many view this work model as an adventure and a means to stay engaged in the industry during uncertain times.

As the biopharma sector continues to evolve, fractional roles may become a lasting feature of the employment landscape, offering companies flexibility and professionals new avenues for career growth and engagement.